CLASS II Device recall · Reported 13 Mar 2019 · FDA Enforcement Report

C2 CryoBalloon Controller recalled by PENTAX of America

Pentax of America is recalling C2 CryoBalloon Controller, distributed nationwide in the US. The recall was initiated on 3 Dec 2018 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesAll lot numbers
Quantity recalled45

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0970-2019
FDA event ID
81695
Recalling firm
Pentax of America, Redwood City, CA
Classification
Class II
Status
Terminated
Recall initiated
3 Dec 2018
FDA classified
1 Mar 2019
Reported
13 Mar 2019
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Device Malfunction

Timeline

3 Dec 2018Recall initiated by company
1 Mar 2019Classified by FDA+88 days
13 Mar 2019Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

The Controller does not detect overpressure in the balloon during the application of non-dosing puffs of Nitrous Oxide, which can contribute to balloon over pressurization, if the intended vent lumen of the catheter is significantly occluded to prevent relieving balloon pressure due to a kinked catheter condition.If a patient is exposed to higher than physiologic pressures, adverse events such as perforation or mucosal laceration may occur.

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

C2 CryoBalloon Controller, REF: FG-1017, with Controller Software v1.18.258 The C2 CryoBalloon Ablation System is intended to be used as a cryosurgical tool in the field of general surgery, specifically for endoscopic application and the ablation of dysplastic Barrett s Esophagus.

Where it was distributed

Worldwide Distribution: US (nationwide) to states of:: CA, DC, FL, LA, MA, MD, MN, NC, NJ, NY, OH, PA, SC, TN, TX, VA, WA;; and countries: Canada, Germany, and Netherlands.

Nationwide CaliforniaDistrict of ColumbiaFloridaLouisianaMassachusettsMarylandMinnesotaNorth CarolinaNew JerseyNew YorkOhioPennsylvaniaSouth CarolinaTennesseeTexasVirginiaWashington

Questions about this recall

Why was it recalled?

The Controller does not detect overpressure in the balloon during the application of non-dosing puffs of Nitrous Oxide, which can contribute to balloon over pressurization, if the intended vent lumen of the catheter is significantly occluded to prevent relieving balloon pressure due to a kinked catheter condition.If a patient is exposed to higher than physiologic pressures, adverse events such as perforation or mucosal laceration may occur.

Which lots are affected?

All lot numbers

Where was it sold?

Worldwide Distribution: US (nationwide) to states of:: CA, DC, FL, LA, MA, MD, MN, NC, NJ, NY, OH, PA, SC, TN, TX, VA, WA;; and countries: Canada, Germany, and Netherlands.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Pentax of America

All 33

Other Heart & Vascular Devices recalls

All 6,220